Levetiracetam Tablet
Product Images NDC 55111-182

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 55111-182). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton1 (Carton1)

FDA Label Image

Carton2 (Carton2)

This is a medication label for Levetiracetam Tablets USP, available in 500mg dosage. It contains instructions for storage and dosage, and warns against improper handling. It includes the manufacturer's contact information.*

FDA Label Image

Carton3 (Carton3)

These are Levetiracetam Tablets USP, 750 mg. Each tablet blister pack contains 10 unit dose tablets. The usual dosage is mentioned in the package insert. The uni-dose packaging is crush-resistant and should be stored at controlled room temperature. Any excursions permitted to TEVIS0°C. The product should be kept in its original blister pack and carton.*

FDA Label Image

Container1 (Container1)

This appears to be a medication label for Levetiracetam Tablets USP of 250mg strength. The label indicates that each patient is required to receive a medication guide and there are 120 tablets in the package. The remaining text seems to be gibberish or not in English and may have been errors.*

FDA Label Image

Container2 (Container2)

LEVETIRACETAM Tablets USP 500mg. Not available.*

FDA Label Image

Container3 (Container3)

FDA Label Image

Figure1 (Figure1)

FDA Label Image

Figure2 (Figure2)

FDA Label Image

Figure3 (Figure3)

FDA Label Image

Figure4 (Figure4)

FDA Label Image

Figure5 (Figure5)

This appears to be a table showing the percentage values for "P" and "196%" for Placebo and Levetiracetam. It is not clear what P and 196% represent. Additionally, the table shows that there were 51 participants in the Placebo group and 58 participants in the Levetiracetam group. Further context is needed to understand the significance of these values.*

FDA Label Image

Figure6 (Figure6)

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.